Literature DB >> 30068640

Epstein-Barr Virus-Induced Nodules on Viral Replication Compartments Contain RNA Processing Proteins and a Viral Long Noncoding RNA.

Richard Park1,2, George Miller3,2,4,5.   

Abstract

Profound alterations in host cell nuclear architecture accompany the lytic phase of Epstein-Barr virus (EBV) infection. Viral replication compartments assemble, host chromatin marginalizes to the nuclear periphery, cytoplasmic poly(A)-binding protein translocates to the nucleus, and polyadenylated mRNAs are sequestered within the nucleus. Virus-induced changes to nuclear architecture that contribute to viral host shutoff (VHS) must accommodate selective processing and export of viral mRNAs. Here we describe additional previously unrecognized nuclear alterations during EBV lytic infection in which viral and cellular factors that function in pre-mRNA processing and mRNA export are redistributed. Early during lytic infection, before formation of viral replication compartments, two cellular pre-mRNA splicing factors, SC35 and SON, were dispersed from interchromatin granule clusters, and three mRNA export factors, Y14, ALY, and NXF1, were depleted from the nucleus. During late lytic infection, virus-induced nodular structures (VINORCs) formed at the periphery of viral replication compartments. VINORCs were composed of viral (BMLF1 and BGLF5) and cellular (SC35, SON, SRp20, and NXF1) proteins that mediate pre-mRNA processing and mRNA export. BHLF1 long noncoding RNA was invariably found in VINORCs. VINORCs did not contain other nodular nuclear cellular proteins (PML or coilin), nor did they contain viral proteins (BRLF1 or BMRF1) found exclusively within replication compartments. VINORCs are novel EBV-induced nuclear structures. We propose that EBV-induced dispersal and depletion of pre-mRNA processing and mRNA export factors during early lytic infection contribute to VHS; subsequent relocalization of these pre-mRNA processing and mRNA export proteins to VINORCs and viral replication compartments facilitates selective processing and export of viral mRNAs.IMPORTANCE In order to make protein, mRNA transcribed from DNA in the nucleus must enter the cytoplasm. Nuclear export of mRNA requires correct processing of mRNAs by enzymes that function in splicing and nuclear export. During the Epstein-Barr virus (EBV) lytic cycle, nuclear export of cellular mRNAs is blocked, yet export of viral mRNAs is facilitated. Here we report the dispersal and dramatic reorganization of cellular (SC35, SON, SRp20, Y14, ALY, and NXF1) and viral (BMLF1 and BGLF5) proteins that play key roles in pre-mRNA processing and export of mRNA. These virus-induced nuclear changes culminate in formation of VINORCs, novel nodular structures composed of viral and cellular RNA splicing and export factors. VINORCs localize to the periphery of viral replication compartments, where viral mRNAs reside. These EBV-induced changes in nuclear organization may contribute to blockade of nuclear export of host mRNA, while enabling selective processing and export of viral mRNA.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  BMLF1; Epstein-Barr virus; NXF1; RNA export; RNA processing; SC35; SON; SRp20; nuclear organization; viral host shutoff

Mesh:

Substances:

Year:  2018        PMID: 30068640      PMCID: PMC6158406          DOI: 10.1128/JVI.01254-18

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  120 in total

1.  Association with the cellular export receptor CRM 1 mediates function and intracellular localization of Epstein-Barr virus SM protein, a regulator of gene expression.

Authors:  S M Boyle; V Ruvolo; A K Gupta; S Swaminathan
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

2.  The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.

Authors:  Delphine Galiana-Arnoux; Fabrice Lejeune; Marie-Claude Gesnel; James Stevenin; Richard Breathnach; Fabienne Del Gatto-Konczak
Journal:  J Biol Chem       Date:  2003-06-24       Impact factor: 5.157

Review 3.  Keeping mRNPs in check during assembly and nuclear export.

Authors:  Evelina Tutucci; Françoise Stutz
Journal:  Nat Rev Mol Cell Biol       Date:  2011-06       Impact factor: 94.444

4.  Purification and characterization of pre-mRNA splicing factor SF2 from HeLa cells.

Authors:  A R Krainer; G C Conway; D Kozak
Journal:  Genes Dev       Date:  1990-07       Impact factor: 11.361

5.  Poly(A)-binding protein 1 partially relocalizes to the nucleus during herpes simplex virus type 1 infection in an ICP27-independent manner and does not inhibit virus replication.

Authors:  C Salaun; A I MacDonald; O Larralde; L Howard; K Lochtie; H M Burgess; M Brook; P Malik; N K Gray; S V Graham
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

6.  Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect.

Authors:  W R Hardy; R M Sandri-Goldin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation.

Authors:  Kathryn S Sciabica; Qian J Dai; Rozanne M Sandri-Goldin
Journal:  EMBO J       Date:  2003-04-01       Impact factor: 11.598

8.  The exonuclease and host shutoff functions of the SOX protein of Kaposi's sarcoma-associated herpesvirus are genetically separable.

Authors:  Britt Glaunsinger; Leonard Chavez; Don Ganem
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  The herpes simplex virus regulatory protein ICP27 contributes to the decrease in cellular mRNA levels during infection.

Authors:  M A Hardwicke; R M Sandri-Goldin
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Epstein-Barr virus SM protein functions as an alternative splicing factor.

Authors:  Dinesh Verma; Sankar Swaminathan
Journal:  J Virol       Date:  2008-05-07       Impact factor: 5.103

View more
  7 in total

1.  The BHLF1 Locus of Epstein-Barr Virus Contributes to Viral Latency and B-Cell Immortalization.

Authors:  Kristen D Yetming; Lena N Lupey-Green; Sergei Biryukov; David J Hughes; Elessa M Marendy; Jj L Miranda; Jeffery T Sample
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

Review 2.  Replication Compartments-The Great Survival Strategy for Epstein-Barr Virus Lytic Replication.

Authors:  Atsuko Sugimoto
Journal:  Microorganisms       Date:  2022-04-25

Review 3.  Viral modulation of cellular RNA alternative splicing: A new key player in virus-host interactions?

Authors:  Simon Boudreault; Patricia Roy; Guy Lemay; Martin Bisaillon
Journal:  Wiley Interdiscip Rev RNA       Date:  2019-04-29       Impact factor: 9.957

Review 4.  Long noncoding RNAs involvement in Epstein-Barr virus infection and tumorigenesis.

Authors:  Jing Zhang; Xiaohan Li; Jingjin Hu; Pengfei Cao; Qijia Yan; Siwei Zhang; Wei Dang; Jianhong Lu
Journal:  Virol J       Date:  2020-04-09       Impact factor: 4.099

5.  Modification of Nuclear Compartments and the 3D Genome in the Course of a Viral Infection.

Authors:  S V Razin; A A Gavrilov; O V Iarovaia
Journal:  Acta Naturae       Date:  2020 Oct-Dec       Impact factor: 1.845

6.  Human cytomegalovirus RNA2.7 inhibits RNA polymerase II (Pol II) Serine-2 phosphorylation by reducing the interaction between Pol II and phosphorylated cyclin-dependent kinase 9 (pCDK9).

Authors:  Yujing Huang; Xin Guo; Jing Zhang; Jianming Li; Mingyi Xu; Qing Wang; Zhongyang Liu; Yanping Ma; Ying Qi; Qiang Ruan
Journal:  Virol Sin       Date:  2022-02-28       Impact factor: 6.947

7.  Human cytomegalovirus long noncoding RNA4.9 regulates viral DNA replication.

Authors:  Julie Tai-Schmiedel; Sharon Karniely; Betty Lau; Adi Ezra; Erez Eliyahu; Aharon Nachshon; Karen Kerr; Nicolás Suárez; Michal Schwartz; Andrew J Davison; Noam Stern-Ginossar
Journal:  PLoS Pathog       Date:  2020-04-15       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.